Your browser doesn't support javascript.
loading
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Henriksen, Tenna Vesterman; Tarazona, Noelia; Frydendahl, Amanda; Reinert, Thomas; Gimeno-Valiente, Francisco; Carbonell-Asins, Juan Antonio; Sharma, Shruti; Renner, Derrick; Hafez, Dina; Roda, Desamparados; Huerta, Marisol; Roselló, Susana; Madsen, Anders Husted; Løve, Uffe S; Andersen, Per Vadgaard; Thorlacius-Ussing, Ole; Iversen, Lene Hjerrild; Gotschalck, Kåre Andersson; Sethi, Himanshu; Aleshin, Alexey; Cervantes, Andres; Andersen, Claus Lindbjerg.
Affiliation
  • Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Tarazona N; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Frydendahl A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Reinert T; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Gimeno-Valiente F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Carbonell-Asins JA; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Sharma S; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Renner D; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Hafez D; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Roda D; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Huerta M; Bioinformatics and Biostatistics Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Roselló S; Natera, Inc., San Carlos, California.
  • Madsen AH; Natera, Inc., San Carlos, California.
  • Løve US; Natera, Inc., San Carlos, California.
  • Andersen PV; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Thorlacius-Ussing O; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Iversen LH; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Gotschalck KA; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Sethi H; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Aleshin A; Department of Surgery, Regional Hospital Herning, Herning, Denmark.
  • Cervantes A; Department of Surgery, Regional Hospital Viborg, Viborg, Denmark.
  • Andersen CL; Department of Surgery, Odense University Hospital, Odense, Denmark.
Clin Cancer Res ; 28(3): 507-517, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34625408
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Biomarkers, Tumor / Neoplasm, Residual / Circulating Tumor DNA / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Biomarkers, Tumor / Neoplasm, Residual / Circulating Tumor DNA / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Year: 2022 Type: Article